General Deadlines RFAs PARs Post-2020 March Deadlines
General Deadlines
Research Grants - R01 renewal, resubmission, revision March 5, 2020
Research Career Development – all K series renewal, resubmission, revision March 12, 2020
Research Grants - R03, R21, R33, R21/R33, R34, R36 renewal, resubmission, revision March 16, 2020
New Investigator – R01 resubmission* for those applications involved in pilot ONLY March 20, 2020
Complete Listing of RFA's and Text Links
NIH RFA HL-20-001
Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00) March 2, 2020
NIH RFA MH-20-510
Laboratories to Optimize Digital Health (R01) March 2, 2020
NIH RFA RM-20-005
4DN Organization and Function in Human Health and Disease (U01) March 2, 2020
NIH RFA RM-20-008
New Investigator Projects on 4DN Organization and Function in Human Health and Disease (U01) March 2, 2020
NIH RFA ES-19-011
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21) March 2, 2020 (and 2021; 2022)
NIH RFA DK-19-032
KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) March 2, 2021
NIH RFA RM-20-001
Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3) March 3, 2020
NIH RFA RM-20-002
Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54) March 3, 2020
NIH RFA FD-20-017
Transferring Harmonized Laboratory Data from healthcare Institutions to Registries Using FHIR Protocols (U01) March 4, 2020
NIH RFA HL-21-022
Bench to Basinet Program Administrative Coordinating Center (U01) March 6, 2020
NIH RFA MH-19-147
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01) March 8, 2020 (and March 4, 2021)
NIH PAR-19-099
Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01) March 9, 2020 (and March 8, 2021)
NIH RFA HL-20-022
Enabling Technologies and Transformative Platforms for HLBS Research (R33) March 9, 2020 (and 2021)
NIH RFA HL-20-023
Catalyze: Product Definition for Small Molecules and Biologics-Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33) March 9, 2020 (and 2021)
NIH RFA HL-20-024
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development and Research Tool Development (R61/R33) March 9, 2020 (and 2021)
NIH RFA HL-20-027
Catalyze: Product Definition for Small Molecules and Biologics-Preliminary Product/Lead Series Identification (R33) March 9, 2020 (and 2021)
NIH RFA HL-20-028
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization and Research Tool Testing and Validation (R33) March 9, 2020 (and 2021)
NIH RFA MH-20-205
Early Psychosis Intervention Network (EPINET): Practice-Based Research to Improve Treatment Outcomes (R01) March 10, 2020
NIH RFA NS-18-046
Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33) March 12, 2020
NIH RFA NS-18-041
Discovery of Biomarkers, Biomarker Signatures and Endpoints for Pain (R61/R33) March 12, 2020
NIH RFA DK-19-022 (and -23) Check website for Clinical Trial Options
Type 1 Diabetes in Acute Pancreatitis Consortium-Clinical Centers (T1DAPC-CCs) (U01) March 13, 2020
NIH RFA MD-20-005
Methods and Measurement in Research with Sexual and Gender Minority (SGM) Populations (R21) March 13, 2020
NIH RFA NS-20-007
Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61.R33) March 17, 2020
NIH RFA RM-20-003
Real Time Chromatin Dynamics and Function (U01) March 17, 2020
NIH RFA RM-20-004
4DN Centers for Data Integration, Modeling and Visualization (UM1) March 17, 2020
NIH RFA AI-19-065
Understanding Phage: Biology to Support the Development of Bacteriophage Therapy (R21) March 18, 2020
NIH RFA NS-20-027
Accelerating Medicine Partnership in Parkinson's Disease (AMP PD) Data Use and Analysis (U01) March 18, 2020
NIH RFA AA-20-006
Impact of Alcohol on the Onset and Progression of Alzheimers Disease and its Related Dementias (R01) March 24, 2020
NIH RFA NS-20-006
BRAIN Initiative Biology and Biophysics of Neural Stimulation and Recording Technologies (R01) March 24, 2020
NIH RFA HL-20-031
HEAL Initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33) March 24, 2020
NIH RFA NS-20-028
HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) March 24, 2020
NIH RFA DK-19-026
New Investigator Gateway Awards for Collaborative T1D Research (R03) March 25, 2020
NIH RFA DK-19-021
Treating diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01) March 26, 2020
NIH RFA AA-20-007
Medications Development for the Treatment of Alcohol Use Disorder (AUD) or Alcohol-Related Organ Damage (AROD) or the Combination of AUD and AROD (U01) March 26, 2020
NIH RFA AT-20-004
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3) March 30, 2020
NIH RFA OD-20-012
Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42) March 30, 2020
NIH RFA DK-19-033
Exploratory Centers for Interdisciplinary Research in Benign Urology (P20) March 31, 2020
NIH RFA NS-20-012
Clinical Trials Planning for Symptomatic Vascular Contributions to Cognitive Impairment and Dementia (VCID) (R34) March 31, 2020
NIH RFA HD-21-015
Pediatric Critical Care Conferences (R13) March 31, 2020
NIH RFA HD-21-012
National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50) March 31, 2020
NIH RFA HD-21-013
Developmental Mechanisms of Human Structural Birth Defects (P01) March 31, 2020
NIH RFA NS-20-019
White Matter Lesion Etiology of Dementia in the US Including in Health Disparity Populations (U19) March 31, 2019
NIH RFA DK-19-034
Urology Centers Program Interactions Core (U24) March 31, 2020
Complete Listing of PAR's and Text Links
Non-Annual
NIH PAR-20-090
NIAMS Clinical Trial Planning Grant (R34) March 2, 2020 (and March 1, 2021; and 2022)
NIH PAR-17-270
NIDDK Central Repositories Non-Renewable Sample Access (X01) March 3, 2020
NIH PAR-18-597
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic and Skin Diseases (R01) March 3, 2020
NIH PAR-18-830
The Role of Epitransciptomics in Development and Disease (R01) March 3, 2020
NIH PAR-18-831
The Role of Epitransciptomics in Development and Disease (R21) March 3, 2020
NIH PAR-18-594
NIAMS Clinical Trials Implementation Cooperative Agreement (U01) March 3, 2020
NIH PAR-18-595
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21) March 3, 2020
NIH PAR-19-319
NIDDK Central Repositories Non-Renewable Sample Access (X01) March 3, 2020 (and March 2, 2021; March 1, 2022)
NIH PAR-19-093
Leveraging Health Information Technology (Health IT) To Address Minority Health and Health Disparities (R01) March 4, 2020 (and 2021)
NIH PAR-19-018
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S. - The Role of Risk and Protective Factors (R01) March 4, 2020 (and 2021)
NIH PAR-19-019
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.-The Role of Risk and Protective Factors (R21) March 4, 2020 (and 2021)
NIH PAR-20-062
Co-infection and Cancer PAR-20-062
NIH PAR-18-869
Modular R01s in Cancer Control and Population Sciences (R01) March 6, 2020 (and March 8, 2021)
NIH PAR-19-100
Limited Competition; Clinical and Translational Science Award (CTSA Program: Exploratory Collaborative Innovation Awards (R21) March 8, 2020 (and 2021)
NIH PAR-18-854
Time-Sensitive Obesity Policy and Program Evaluation (R01) March 10, 2020 (and 2021)
NIH PAR-19-070
Research on Current Topics in Alzheimer's Disease and its Related Dementias (R01) March 11, 2020 (and 2021)
NIH PAR-19-071
Research on Current Topics in Alzheimer's Disease and it's Related Dementias (R21) March 11, 2020 (and 2021)
NIH PAR-19-361
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01) March 11, 2020 (and 2021;2022)
NIH PAR-18-319
HIV Vaccine Research and Design (HIVRAD) Program (P01) March 13, 2020
NIH PAR-17-315
Pre-Application for a Biomedical Technology Research Resource (X02) March 15, 2020
NIH PAR-19-197
Summer Research Education Experience Program (R25) March 17, 2020 (and 2021)
NIH PAR-20-086
Biomedical Research Facilities (C06) March 17, 2020
NIH PAR-20-061
Co-infection and Cancer (R21) March 17, 2021
PAR-19-384
Research on Biopsychosocial factors of social Connectedness and isolation on Health, Well-being, Illness and Recovery (R01) March 17, 2020; 2021
NIH PAR-19-373
Research on bio-psycho-social factors of social connectedness and isolation on health, well-being, illness and recovery (R01) March 17, 2020 (and 2021)
NIH PAR-19-373
Research on Biopsychosocial Factors of Social connectedness and Isolation on Health, Well-Being, Illness and Recovery (r01) March 17, 2020; and 2021
NIH PAR-19-384
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Well Being, illness and Recovery (r01) March 17,2020; (and March 17, 2021)
NIH PAR-20-035
Integrative Research on Polysubstance Abuse and Disorder (R61/R33) March 17, 2020 (and 2021; 2022)
NIH PAR-20-075
NIDDK Program Projects (P01) March 18, 2020 (first deadline, regular deadlines follow)
NIH PAR-18-789
Genetic Analysis of Non-Human Animal Models to Understand the Genomic Architecture of Substance Use Disorders and Addictive Behaviors (U01) March 19, 2020 (and 2021)
NIH PAR-19-212
Behavioral and Integrative Treatment Development Program (R01) March 23, 2020 (and 2021, 2022)
NIH PAR-19-213
Behavioral and Integrative Treatment Development Program (R34) March 23, 2020 (and 2021, 2022)
NIH PAR-20-085
Pilot Centers for Precision Disease Modeling (U54) March 24, 2020
NIH PAR-18-494
Device-Based Treatments for Substance Use Disorders (UG3/UH3) March 27, 2020
NIH PAR-18-411
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01) March 30, 2020
March Deadlines, Post-2020
NIH RFA OD-19-021
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21) March 8, 2021
NIH RFA OD-19-022
Secondary Analysis of Existing Datasets of Tobacco Use and Health (R21) March 8, 2021
NIH PAR-19-282
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33) March 10, 2021; March 10, 2023
